Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes.

MLA

Tsai, S. T., et al. “Expression of EBER1 in Primary and Metastatic Nasopharyngeal Carcinoma Tissues Using in Situ Hybridization. A Correlation with WHO Histologic Subtypes.” Cancer, vol. 77, no. 2, Jan. 1996, pp. 231–36. EBSCOhost, https://doi.org/10.1002/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.0.CO;2-P.

APA

Tsai, S. T., Jin, Y. T., & Su, I. J. (1996). Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes. Cancer, 77(2), 231–236. https://doi.org/10.1002/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.0.CO;2-P

Chicago

Tsai, S T, Y T Jin, and I J Su. 1996. “Expression of EBER1 in Primary and Metastatic Nasopharyngeal Carcinoma Tissues Using in Situ Hybridization. A Correlation with WHO Histologic Subtypes.” Cancer 77 (2): 231–36. doi:10.1002/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.0.CO;2-P.